Early detection and treatment are key to improving outcomes, reducing costs.
Each year, more than 1.6 million Americans contract sepsis, a dangerous disease process that kills 258,000 people and leaves thousands of survivors with lifelong aftereffects. Difficult to diagnose and treat, sepsis accounts for more than $20 billion in annual costs (PDF) to the U.S. health care system, making it the most expensive condition treated in hospitals. It results in significant costs related to intensive therapies and is a frequent cause of readmissions to acute care.
Early detection and treatment are key to improving sepsis survival rates and reducing the high cost of care. In our role as a Quality Innovation Network Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services, TMF is working on a sepsis initiative with providers to increase awareness of potential sepsis patients, and avert sepsis with early detection and intervention in inpatient and outpatient acute-care settings.